Generated by AI
Atossa Therapeutics Inc. is a clinical-stage biopharmaceutical company focused on developing therapies for breast cancer and other breast health conditions. The company’s work centers on oncology, with an emphasis on hormone-driven disease areas and related unmet medical needs. Its current pipeline includes investigational medicines and therapeutic programs designed to address breast cancer prevention and treatment, as well as selected rare diseases where estrogen-related biology may be relevant. Atossa Therapeutics also advances diagnostic capabilities connected to breast health, supporting a broader approach to disease management. Based in Seattle, Washington, the company operates within the biotechnology sector and plays a role in translating research into potential treatment options for women’s health and cancer care.
Website448 NW Market Street
Seattle, WA, 98107
United States
The latest articles about ATOS.
Detailed price information for Hcw Biologics Inc (HCWB-Q) from The Globe and Mail including charting and trades.
Summary of Nov 16's posts. Generated by AI.
Summary of Feb 3's posts. Generated by AI.
Shareholders could be set for a cash reward if the biotech wins a voucher upon approval of (Z)-endoxifen.
Summary of Jul 29's posts. Generated by AI.
Investors talking about ATOS also mention these. Each card shows that asset’s own numbers for the past 24 hours.
Valuation and earnings.